R. Fleischmann

848 total citations
28 papers, 561 citations indexed

About

R. Fleischmann is a scholar working on Molecular Biology, Inorganic Chemistry and Clinical Biochemistry. According to data from OpenAlex, R. Fleischmann has authored 28 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Inorganic Chemistry and 4 papers in Clinical Biochemistry. Recurrent topics in R. Fleischmann's work include Metabolism and Genetic Disorders (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Asymmetric Hydrogenation and Catalysis (4 papers). R. Fleischmann is often cited by papers focused on Metabolism and Genetic Disorders (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Asymmetric Hydrogenation and Catalysis (4 papers). R. Fleischmann collaborates with scholars based in Germany, United States and Austria. R. Fleischmann's co-authors include H. Remmer, B. Schoene, H.-F. v. Oldershausen, Hansruedi Glatt, Franz Oesch, H. L. Mallika Bohm, Walter Strohmeier, J. Lorenz, R Ferlinz and H. Mattenheimer and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Electrochimica Acta and Annals of the Rheumatic Diseases.

In The Last Decade

R. Fleischmann

26 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Fleischmann Germany 10 302 132 123 74 72 28 561
H. Noguchi Japan 15 223 0.7× 211 1.6× 196 1.6× 31 0.4× 44 0.6× 58 641
L Clejan United States 17 157 0.5× 379 2.9× 58 0.5× 32 0.4× 57 0.8× 36 652
Hilman W. Culp United States 13 147 0.5× 195 1.5× 132 1.1× 31 0.4× 73 1.0× 19 641
Julia Rashba-Step United States 7 149 0.5× 207 1.6× 72 0.6× 39 0.5× 125 1.7× 7 545
J. D. Baty United Kingdom 15 131 0.4× 241 1.8× 99 0.8× 26 0.4× 33 0.5× 56 843
Shmuel Zbáida Israel 11 213 0.7× 147 1.1× 128 1.0× 42 0.6× 23 0.3× 23 588
Joseph Auerbach United States 12 59 0.2× 296 2.2× 94 0.8× 32 0.4× 44 0.6× 19 891
Jaroslav Mráz Czechia 17 158 0.5× 206 1.6× 64 0.5× 250 3.4× 82 1.1× 62 751
Charles E. Ruegg United States 9 177 0.6× 155 1.2× 120 1.0× 18 0.2× 18 0.3× 12 469
Tsutomu Yoshimura Japan 13 171 0.6× 205 1.6× 183 1.5× 36 0.5× 48 0.7× 28 594

Countries citing papers authored by R. Fleischmann

Since Specialization
Citations

This map shows the geographic impact of R. Fleischmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Fleischmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Fleischmann more than expected).

Fields of papers citing papers by R. Fleischmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Fleischmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Fleischmann. The network helps show where R. Fleischmann may publish in the future.

Co-authorship network of co-authors of R. Fleischmann

This figure shows the co-authorship network connecting the top 25 collaborators of R. Fleischmann. A scholar is included among the top collaborators of R. Fleischmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Fleischmann. R. Fleischmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mease, Philip, et al.. (2014). Long-Term Safety and Efficacy of Certolizumab Pegol over 96 Weeks in Patients with Psoriatic Arthritis with and without Prior Tumor Necrosis Factor Inhibitor Exposure. Data Archiving and Networked Services (DANS). 1 indexed citations
2.
Kavanaugh, Arthur, R. Fleischmann, Paul Emery, et al.. (2012). SAT0122 Efficacy of addition, or continuation, of adalimumab in patients who did not achieve stable low disease activity with methotrexate or adalimumab plus methotrexate in the optima study. Annals of the Rheumatic Diseases. 71. 511–512. 3 indexed citations
3.
4.
Keystone, E., R. Fleischmann, J S Smolen, et al.. (2010). THE EFFICACY OF CERTOLIZUMAB PEGOL ADDED TO METHOTREXATE IS SUSTAINED OVER 2 YEARS IN THE TREATMENT OF RHEUMATOID ARTHRITIS. Lara D. Veeken. 49. 1 indexed citations
5.
Messmann, Helmut, et al.. (2004). Lehratlas der Koloskopie.
6.
Fleischmann, R., et al.. (1997). [Angiosarcoma of the spleen. Case report and review of the literature].. PubMed. 382(4). 226–30. 6 indexed citations
7.
Fleischmann, R., et al.. (1986). Induction of cytochrome P-448 iso-enzymes and related glucuronyltransferases in the human liver by cigarette smoking. European Journal of Clinical Pharmacology. 30(4). 475–480. 34 indexed citations
8.
Fleischmann, R., et al.. (1985). Interindividual variations in the activities of cytosolic and microsomal epoxide hydrolase in human liver. Carcinogenesis. 6(2). 219–223. 54 indexed citations
9.
Lorenz, J., Hansruedi Glatt, R. Fleischmann, R Ferlinz, & Franz Oesch. (1984). Drug metabolism in man and its relationship to that in three rodent species: Monooxygenase, epoxide hydrolase, and glutathione S-transferase activities in subcellular fractions of lung and liver. Biochemical Medicine. 32(1). 43–56. 68 indexed citations
10.
Fleischmann, R., et al.. (1984). Some aspects of the electrophoretic enamel deposition. Electrochimica Acta. 29(1). 77–80. 2 indexed citations
11.
Fleischmann, R. & H. L. Mallika Bohm. (1980). Brennstoffzellenaggregat mit Wolframcarbid als Anodenkatalysator. Berichte der Bunsengesellschaft für physikalische Chemie. 84(10). 1023–1026. 9 indexed citations
12.
Fleischmann, R. & H.P. Boehm. (1978). ChemInform Abstract: HYDROGEN OXIDATION ON DIFFERENT TUNGSTEN CARBIDE MATERIALS. Chemischer Informationsdienst. 9(1). 1 indexed citations
13.
Schoene, B., et al.. (1974). [Activity of benzopyrene hydrolase in human liver-biopsy specimens in vitro and its relationship to the elimination speed of glycodiazine in vivo].. PubMed. 80. 501–3. 3 indexed citations
14.
Remmer, H., B. Schoene, & R. Fleischmann. (1973). INDUCTION OF THE UNSPECIFIC MICROSOMAL HYDROXYLASE IN THE HUMAN LIVER. Drug Metabolism and Disposition. 1(1). 224–230. 12 indexed citations
15.
Strohmeier, Walter & R. Fleischmann. (1972). Katalytische isomerisierung von heptenen mit IrX(CO)L2. Journal of Organometallic Chemistry. 42(1). 163–168. 4 indexed citations
16.
Schoene, B., R. Fleischmann, H. Remmer, & H.-F. v. Oldershausen. (1972). Determination of drug metabolizing enzymes in needle biopsies of human liver. European Journal of Clinical Pharmacology. 4(2). 65–73. 273 indexed citations
17.
Strohmeier, Walter & R. Fleischmann. (1971). Selektivität des homogenen Hydrierungskatalysators IrX(CO)L2 als Funktion der Liganden X und L. Journal of Organometallic Chemistry. 29(2). C39–C41. 1 indexed citations
18.
Strohmeier, Walter, et al.. (1970). Notizen: Einfluß des Zentralatoms Me in den Hydrierungskatalysatoren MeCl(CO)[PΦ3]2 auf die Hydrierungsgeschwindigkeit ungesättigter Verbindungen. Zeitschrift für Naturforschung B. 25(12). 1481–1482. 4 indexed citations
19.
Strohmeier, Walter & R. Fleischmann. (1969). Gleichgewichte zwischen dem homogenen Hydrierungskatalysator IrX(CO)L2 und ungesättigten Verbindungen. Zeitschrift für Naturforschung B. 24(10). 1217–1219. 12 indexed citations
20.
Fleischmann, R. & P. Jordan. (1957). WALTER BOTHE/WILHELM LENZ. Physikalische Blätter. 13(6). 268–270.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Noguchi Breakdown of academic impact, for papers by L Clejan Breakdown of academic impact, for papers by Hilman W. Culp Breakdown of academic impact, for papers by Julia Rashba-Step Breakdown of academic impact, for papers by J. D. Baty Breakdown of academic impact, for papers by Shmuel Zbáida Breakdown of academic impact, for papers by Joseph Auerbach Breakdown of academic impact, for papers by Jaroslav Mráz Breakdown of academic impact, for papers by Charles E. Ruegg Breakdown of academic impact, for papers by Tsutomu Yoshimura
Rankless by CCL
2026